The Patent Finder

Sana Biotechnology, Inc.

11 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2038
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Methods and Compositions for Modulating Car-T Activity (US 11,802,157) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 2 fees due Aug 20, 2027
  • 1 fee due Oct 23, 2027
    The maintenance fee for Methods and Compositions for Modulating Car-T Activity (US 11,965,022) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US D991,484Cryogenic cassette
In force
 · USPTO record
In forceUSPTO record
US D1,063,103Cryogenic Vial Storage Rack Assembly
In force
 · High confidence
In forceHigh confidence
US 12,751,977Methods and Compositions of Chondrisomes
In force
 · Medium confidence
In forceMedium confidence
US 11,903,974Methods and Compositions Relating to Chondrisomes from Cultured Cells
In force
 · High confidence
In forceHigh confidence
US 11,903,975Methods and Compositions Relating to Chondrisomes from Blood Products
In force
 · High confidence
In forceHigh confidence
US 11,802,157Methods and Compositions for Modulating Car-T Activity
In force
 · High confidence
In forceHigh confidence
US 11,965,022Methods and Compositions for Modulating Car-T Activity
In force
 · High confidence
In forceHigh confidence
US 11,987,628Methods and Compositions for Modulating Car-T Activity
In force
 · High confidence
In forceHigh confidence
US 11,535,869CD8-SPECIFIC Antibody Constructs and Compositions Thereof
In force
 · High confidence
In forceHigh confidence
US 12,674,180CD8-SPECIFIC Antibody Constructs and Compositions Thereof
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

33 pending · 7 abandoned · 6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited